Annual check-ups save lives by detecting prostate issues early, yet many men avoid these crucial tests due to fear or misconceptions. Prostate health ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Vir Biotechnology's Phase 1 trials reveal promising safety and efficacy for dual-masked T-cell engagers targeting HER2 and ...

Kearney Urology Center has reported a 50% reduction in biopsies since adopting EpiSwitch PSE, a new accurate blood test for ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

The new test has demonstrated an initial 94% sensitivity rate in tumour detection and the test is delivered in under 20 ...

Black men are "put in disproportionate danger of dying" from prostate cancer due to health inequities and outdated NHS ...

After skin cancer, prostate cancer is the most common cancer in men in the US. A new treatment is giving men more options.

Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

Kearney Urology Center has reported a 50% reduction in biopsies since adopting EpiSwitch® PSE, a new accurate blood test for prostate cancer. The reduction is down to the marked improvement offered by ...